Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ried

Showing results (211-220 of 257) with videos related to

Pageof 26
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Disease Models & Mechanisms|September 27, 2021
TP53 loss initiates chromosomal instability in fallopian tube epithelial cellsDaniel Bronder, Anthony Tighe, Darawalee Wangsa, et al.
Oncogene|November 25, 2003
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processingRyan J Whitmarsh, Charles Saginario, Ya Zhuo, et al.
Genes & Development|July 16, 2021
Clonal selection of stable aneuploidies in progenitor cells drives high-prevalence tumorigenesisMarianna Trakala, Muskaan Aggarwal, Courtney Sniffen, et al.
Plos One|August 9, 2017
Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumorEster Rozenblum, Jose R Sotelo-Silveira, Gina Y Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
The American Journal of Pathology|October 16, 2012
Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progressionKerstin Heselmeyer-Haddad, Lissa Y Berroa Garcia, Amanda Bradley, et al.
The American Journal of Pathology|May 17, 2020
High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer PatientsAyla Koçak, Kerstin Heselmeyer-Haddad, Annette Lischka, et al.
BMC Genomics|November 22, 2015
Quantitative analysis of chromatin interaction changes upon a 4.3 Mb deletion at mouse 4E2Cinthya J Zepeda-Mendoza, Swagatam Mukhopadhyay, Emily S Wong, et al.
Genes, Chromosomes & Cancer|April 8, 2020
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatmentsDarmood Wei, Youfeng Yang, Christopher J Ricketts, et al.
Pageof 26

Showing results (211-220 of 257) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Disease Models & Mechanisms|September 27, 2021
TP53 loss initiates chromosomal instability in fallopian tube epithelial cellsDaniel Bronder, Anthony Tighe, Darawalee Wangsa, et al.
Oncogene|November 25, 2003
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processingRyan J Whitmarsh, Charles Saginario, Ya Zhuo, et al.
Genes & Development|July 16, 2021
Clonal selection of stable aneuploidies in progenitor cells drives high-prevalence tumorigenesisMarianna Trakala, Muskaan Aggarwal, Courtney Sniffen, et al.
Plos One|August 9, 2017
Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumorEster Rozenblum, Jose R Sotelo-Silveira, Gina Y Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
The American Journal of Pathology|October 16, 2012
Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progressionKerstin Heselmeyer-Haddad, Lissa Y Berroa Garcia, Amanda Bradley, et al.
The American Journal of Pathology|May 17, 2020
High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer PatientsAyla Koçak, Kerstin Heselmeyer-Haddad, Annette Lischka, et al.
BMC Genomics|November 22, 2015
Quantitative analysis of chromatin interaction changes upon a 4.3 Mb deletion at mouse 4E2Cinthya J Zepeda-Mendoza, Swagatam Mukhopadhyay, Emily S Wong, et al.
Genes, Chromosomes & Cancer|April 8, 2020
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatmentsDarmood Wei, Youfeng Yang, Christopher J Ricketts, et al.
Pageof 26